Business Description
VitaNova Life Sciences Corp
NAICS : 423460
SIC : 5122
ISIN : US98585W1062
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
VNOV.USA IPO Date
2018-07-12Description
VitaNova Life Sciences Corp, formerly Yijia Group Corp provides business consulting services to domestic and international customers. The Company provides consulting services to its clients with regards to funding and other financial matters.The company's operating segments are The consulting services Segment mainly provides consulting advisory services in management, business, accounting and finance; and the Healthcare Segment mainly provides healthcare products and health consultation services to customers. The sale and distribution of healthcare products, such as Nicotinamide Riboside capsules, has only one performance obligation under the fixed-fee arrangements. and the majority of its revenue generates from Sales of healthcare products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.8 | |||||
Interest Coverage | 598 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 19.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 73.6 | |||||
3-Year FCF Growth Rate | 125.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 0.01 | |||||
3-1 Month Momentum % | -71.43 | |||||
6-1 Month Momentum % | -71.43 | |||||
12-1 Month Momentum % | 155.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.05 | |||||
Quick Ratio | 4.76 | |||||
Cash Ratio | 2.55 | |||||
Days Inventory | 19.99 | |||||
Days Sales Outstanding | 96.5 | |||||
Days Payable | 24.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -62.1 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.45 | |||||
Operating Margin % | 37.45 | |||||
Net Margin % | 23.36 | |||||
EBITDA Margin % | 37.45 | |||||
FCF Margin % | 27.11 | |||||
OCF Margin % | 27.11 | |||||
ROE % | 43.22 | |||||
ROA % | 35.64 | |||||
ROIC % | 93.66 | |||||
ROC (Joel Greenblatt) % | 150.74 | |||||
ROCE % | 69.29 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.71 | |||||
PE Ratio without NRI | 19.71 | |||||
PS Ratio | 3.61 | |||||
PB Ratio | 6.22 | |||||
Price-to-Tangible-Book | 6.27 | |||||
Price-to-Free-Cash-Flow | 13.27 | |||||
Price-to-Operating-Cash-Flow | 13.27 | |||||
EV-to-EBIT | 8.64 | |||||
EV-to-EBITDA | 8.64 | |||||
EV-to-Revenue | 3.24 | |||||
EV-to-FCF | 11.94 | |||||
Price-to-GF-Value | 0.23 | |||||
Price-to-Projected-FCF | 6.9 | |||||
Price-to-Graham-Number | 2.34 | |||||
| Price-to-Net-Current-Asset-Value | 6.27 | |||||
| Price-to-Net-Cash | 15.33 | |||||
Earnings Yield (Greenblatt) % | 11.57 | |||||
FCF Yield % | 7.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VNOV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VitaNova Life Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.194 | ||
| EPS (TTM) ($) | 0.07 | ||
| Beta | 0.5626 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 2.52 | ||
| Volatility % | 804.09 | ||
| 14-Day RSI | 0.01 | ||
| 14-Day ATR ($) | 0.002708 | ||
| 20-Day SMA ($) | 1.38 | ||
| 12-1 Month Momentum % | 155.56 | ||
| 52-Week Range ($) | 0.4233 - 7.5 | ||
| Shares Outstanding (Mil) | 8.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VitaNova Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VitaNova Life Sciences Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.333333:1 Stock Split | 2026-01-27 | 4.83 (+0.00%) |
Show
Entries
VitaNova Life Sciences Corp Frequently Asked Questions
What is VitaNova Life Sciences Corp(VNOV)'s stock price today?
The current price of VNOV is $1.38. The 52 week high of VNOV is $7.50 and 52 week low is $0.42.
When is next earnings date of VitaNova Life Sciences Corp(VNOV)?
The next earnings date of VitaNova Life Sciences Corp(VNOV) is .
Does VitaNova Life Sciences Corp(VNOV) pay dividends? If so, how much?
VitaNova Life Sciences Corp(VNOV) does not pay dividend.
Guru Commentaries on OTCPK:VNOV
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on VitaNova Life Sciences Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers